Using ChatGPT is a lot simpler than you think, and there are many ways to make it work best for you. Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest ...

When an ulcer creates an actual perforation in the digestive tract, surgery is currently the only treatment. In the ...

Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's ...

In a groundbreaking study, scientists have discovered more than 100 new human viruses in 252 different gut microbes, ...

The company is selling the rights to a drug candidate aimed at rare blood and kidney disorders.

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

The deal gives Novo rights to a drug it sees as having "multiple advantages" over other treatments for so-called ...

Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30, Novartis announced the US FDA approval of ...

Jeremy S Abramson and colleagues reported that glofitamab plus gemcitabine and oxaliplatin (GemOx) significantly improved overall survival (OS) in transplant-ineligible patients with relapsed or ...

The addition of navtemadlin to ruxolitinib for JAK inhibitor-naive patients with myelofibrosis with suboptimal response to ...